Furthermore, adiponectin, which is decreased in obese patients, can inhibit in vitro tumor growth through an adenosine monophosphate (AMP)-activated protein kinase and act as an inhibitor of cancer angiogenesis [38,39]. This evidence concerns the gene WEE1 and cancer.